Becker's Hospital Review - Cardiology
APRIL 3, 2024
The FDA has approved an artificial intelligence algorithm for Eko Health's digital stethoscope that can detect low ejection fraction, a key indicator of heart failure.
DAIC
APRIL 3, 2024
milla1cf Wed, 04/03/2024 - 18:55 April 3, 2024 — - Eko Health , a pioneer in applying artificial intelligence ( AI ) for early detection of heart and lung diseases, announces FDA clearance for its Low EF detection AI. For the first time, U.S. healthcare providers can now detect Low EF, a key heart failure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination.
HCPLive
APRIL 3, 2024
Our March 2024 month-in-review in hematology features updates to the anemia pipeline, the latest research in sickle cell disease, and the role of SGLT2 inhibition on hematologic outcomes.
DAIC
APRIL 3, 2024
April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization, the American College of Cardiology (ACC) has planned a full range of educational programming, special events and peer networking scheduled throughout the April 6-8 event in Atlanta, GA. Here is an overview of sessions, events and meetings coordinated to help members in particular specialties, sections and areas of interest learn and engage with peers and expert cardiology pro
Science Daily - Heart Disease
APRIL 3, 2024
Global life expectancy increased by 6.2 years since 1990, according to a new study. Over the past three decades, reductions in death from leading killers fueled this progress, including diarrhea and lower respiratory infections, as well as stroke and ischemic heart disease. When the COVID-19 pandemic arrived in 2020, however, it derailed progress in many locations.
DAIC
APRIL 3, 2024
milla1cf Wed, 04/03/2024 - 10:04 April 3, 2024 — The U.S. Food and Drug Administration ( FDA ) announced that Teleflex and Arrow International are recalling the ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits after receiving reports of increased resistance in the guidewire handle and chamber during use. This issue may cause serious injury, including injury to blood vessel walls, narrowing of the blood vessels (vasospasm), artery blockage (embolism), or deat
HCPLive
APRIL 3, 2024
Manuel Litchman, MD, further discusses Mustang Bio's expansion into autoimmune diseases with MB-106, an autologous CAR T-cell therapy.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
American Heart News - Heart News
APRIL 3, 2024
Research Highlights: Asian American adults with more unfavorable factors related to income level, education, housing, access to health care and other social variables had a greater likelihood of having risk factors for cardiovascular disease in this.
Medical Xpress - Cardiology
APRIL 3, 2024
Over the last three decades, heart disease deaths have plummeted in the US, but a new study suggests cardiovascular benefits apply only to people in higher-income populations. For poor populations, heart attack rates stayed the same or got worse during that 30-year period.
Med Page Today
APRIL 3, 2024
(MedPage Today) -- Note that some links may require registration or subscription. An emergency department worker in Minnesota sustained serious injuries after being stabbed by a 31-year-old patient. (Fox9) A third of LGBT patients said they were.
HCPLive
APRIL 3, 2024
The study found the odds of a perinatal PTSD diagnosis were greater for people aged 15 – 26 years, more comorbidities, and a lower income of poverty.
The New England Journal of Medicine
APRIL 3, 2024
More than half of newly diagnosed cases of type 1 diabetes occur in adulthood. This review focuses on the prevention of cardiovascular disease in patients with type 1 diabetes.
Med Page Today
APRIL 3, 2024
(MedPage Today) -- Using a personalized algorithm to identify primary care patients with chronic kidney disease (CKD), type 2 diabetes, and hypertension (the kidney-dysfunction triad) -- plus practice facilitators to help providers deliver guideline.
The New England Journal of Medicine
APRIL 3, 2024
This feature about a women with AF triggered by sepsis offers a case vignette accompanied by two essays, one supporting oral anticoagulant therapy after discharge and the other recommending no anticoagulant therapy.
Medical Xpress - Cardiology
APRIL 3, 2024
Many studies have shown that potentially lethal heart rhythm disturbances ('ventricular arrhythmia') are more likely to occur in the morning, when people wake after a night's sleep, but until now the trigger mechanism has not been fully understood.
CardiacWire
APRIL 3, 2024
There are over 70 million chest X-rays performed in the U.S. every year, and a pair of new studies highlighted how AI could be used to “opportunistically screen” these exams for undetected cardiovascular disease. A Mass General Brigham team writing in the Annals of Internal Medicine detailed how their deep learning system was able to identify patients with greater 10-year risks of experiencing major cardiovascular events by analyzing their chest X-rays.
HCPLive
APRIL 3, 2024
Manuel Litchman, MD, discusses Mustang Bio's expansion into autoimmune diseases with MB-106, an autologous CAR T-cell therapy.
Circulation
APRIL 3, 2024
Circulation, Ahead of Print. Guideline-directed medical therapies and guideline-directed nonpharmacological therapies improve quality of life and survival in patients with heart failure (HF), but eligible patients, particularly women and individuals from underrepresented racial and ethnic groups, are often not treated with these therapies. Implementation science uses evidence-based theories and frameworks to identify strategies that facilitate uptake of evidence to improve health.
Science Daily - Heart Disease
APRIL 3, 2024
Asian American adults with more unfavorable factors related to income level, education, housing, access to health care and other social variables had a greater likelihood of having risk factors for cardiovascular disease in this study.
International Journal of Cardiovascular Sciences
APRIL 3, 2024
Dear authors, we would like to inform you that our journal submission system is experiencing technical issues, and submissions are temporarily unavailable. We are aware of the situation and are working to rectify the error as quickly as possible. We apologize for any inconvenience this may cause and kindly request understanding from all affected authors.
ADN Center of Excellence
APRIL 3, 2024
In the rapidly evolving landscape of medicine, simulation-based training has emerged as a pivotal tool in medical education, offering a realistic and safe environment to practice various procedures and scenarios. For doctors in different fields of medicine, this form of training is invaluable, providing numerous benefits that translate to improved patient care and outcomes.
HCPLive
APRIL 3, 2024
Participants who received facilitated telemedicine initiated DAA therapy faster and had greater cure rates than those who were referred to an off-site hepatitis specialist.
Nature Reviews - Cardiology
APRIL 3, 2024
Nature Reviews Cardiology, Published online: 04 April 2024; doi:10.1038/s41569-024-01009-x In this Review, van Leent and colleagues provide an overview of current PET imaging approaches for assessment of atherosclerotic cardiovascular disease, as well as of whole-body PET applications; discuss the link between imaging readouts and atherosclerotic plaque pathology; and highlight promising developments in PET systems and radiotracer synthesis.
HCPLive
APRIL 3, 2024
In this endocrinology month in review for March 2024, we recap the most popular FDA news and pipeline updates as well as recognizing the 2-year anniversary of Diabetes Dialogue.
Medical Xpress - Cardiology
APRIL 3, 2024
Having more unfavorable social determinants of health, such as being unemployed, uninsured or not having education beyond high school, was associated with an increased likelihood of having risk factors for cardiovascular disease among Asian American adults, according to new research published today in the Journal of the American Heart Association.
HCPLive
APRIL 3, 2024
In this Month in Review article for March, news on topics such as asthma and the impacts of pollution in the pulmonology field were highlighted.
Stroke Journal
APRIL 3, 2024
Stroke, Ahead of Print. BACKGROUND:Poststroke depression (PSD) is a treatable and common complication of stroke that is underdiagnosed and undertreated in minority populations. We compared outcomes of Black and White patients with PSD in the United States to assess whether race is independently associated with the risk of recurrent stroke and mortality.METHODS:We used deidentified Medicare data from inpatient, outpatient, and subacute nursing facilities for Black and White US patients from Janua
HCPLive
APRIL 3, 2024
Peter A. Campochiaro, MD, discusses the safety and tolerability of RGX-314 gene therapy in treating wet AMD and how these results inform pivotal clinical trials.
Stroke Journal
APRIL 3, 2024
Stroke, Ahead of Print. BACKGROUND:Moyamoya disease (MMD) is a progressive, occlusive disease of the internal carotid arteries and their proximal branches, with the subsequent development of an abnormal vascular network that is rupture-prone. Steno-occlusive changes in the posterior cerebral arteries (PCAs) may contribute to worsened outcomes in patients with MMD; however, there is little information on the incidence and natural history of posterior circulation MMD (PCMMD).
HCPLive
APRIL 3, 2024
These data may have impactful clinical and health policy implications, given that hospitalizations for CAP are known to be common and given the frequency of incorrect diagnoses.
Journal of Cardiovascular Pharmacology
APRIL 3, 2024
An abstract is unavailable. This article is available as a PDF only.
HCPLive
APRIL 3, 2024
Although still recruiting, the first patient was randomized to receive NBI-1070770 for major depressive disorder in a phase 2 trial assessing efficacy, safety, and tolerability.
Journal of the American Heart Association
APRIL 3, 2024
Journal of the American Heart Association, Ahead of Print.
HCPLive
APRIL 3, 2024
Our March 2024 month in review highlights HCPLive’s top coverage of the latest news in nephrology, ranging from new CKD research and KDIGO guidelines to recent IgAN data.
Journal of the American Heart Association
APRIL 3, 2024
Journal of the American Heart Association, Ahead of Print.
Circulation: Heart Failure
APRIL 3, 2024
Circulation: Heart Failure, Ahead of Print.
Clinical Trial Results
APRIL 3, 2024
Disclosures: TBD
Expert insights. Personalized for you.
115 
Let's personalize your content